Will Lavery

Q: What is Will Lavery email address?

Email Will Lavery at wlavery@velocityclinical.com. This email is the most updated Will Lavery email found in 2026.

Q: How to contact Will Lavery?

To contact Will Lavery send an email to wlavery@velocityclinical.com.

Principal Investigator at Dr. Vince Clinical Research | Overland Park, Kansas, United States

About Will Lavery

Will Lavery serves as the Principal Investigator at Dr. Vince Clinical Research, where he leads a diverse array of early-phase clinical trials that are pivotal in advancing therapeutic innovations. His expertise encompasses first-in-human studies, single ascending dose (SAD) and multiple ascending dose (MAD) trials, as well as complex assessments such as drug-drug interactions and thorough QT (TQT) evaluations. With a strong foundation in Allergy and Immunology, Will is uniquely positioned to conduct specialized studies that address critical areas such as human abuse potential, pain models, and respiratory depression assessments, particularly in relation to tobacco and nicotine products.

At Dr. Vince Clinical Research, Will is instrumental in navigating the regulatory requirements essential for successful trial execution. His board certification by the American Board of Allergy and Immunology underscores his deep understanding of clinical immunology, which is particularly beneficial in trials involving conditions like asthma, atopic dermatitis, and food allergies. His commitment to rigorous clinical research is evident in his meticulous approach to pharmacokinetics and pharmacodynamics (PK/PD), food effect studies, and bioavailability/bioequivalence (BA/BE) assessments, ensuring that each trial adheres to the highest standards of scientific integrity.

Will's collaborative spirit and leadership skills foster an environment of innovation and excellence, enabling his team to conduct groundbreaking research that not only meets regulatory standards but also addresses unmet medical needs. His ongoing projects reflect a commitment to advancing the field of clinical research, ultimately contributing to the development of safer and more effective therapeutic options for patients.

Will Lavery Work